New and Nonofficial Drugs 1959, p. 217. J. B. Lippincott Co., Philadelphia, 1959.
2.
Brucke, F., Hertting, G., Lindner, A., AND Loudon, M.: The pharmacology of a new vasodilating substance of the p-hydroxyephedrine series. Wien. Klin. Wchnschr., 68: 183, 1956.
3.
Kaindl, F., Partan, J., AND Polsterer, P.: Clinical use of a new vasodilator. Wien. Klin. Wchnschr. , 68: 186, 1956.
4.
Weghaupt, K. : Results of treatment with a new vasodilator in patients with severe disturbances of blood supply in the lower extremities . Wien. Klin. Wchnschr., 69: 31,1957.
5.
Singer, R.: Conservative management of the peripheral circulation. Wien. med. Wchnschr., 107: 734, 1957.
6.
Kraucher, C. : Experiences with a new vasodilator in disturbances of blood flow. Prakt. Arzt., 11: 325, 1957.
7.
Kaindl, F., Samuels, S.S., Selman, D., AND Shaftel, H.E.: A new vasodilator and antispasmodic agent: isoxsuprine hydrochloride . Angiology, 10: 185, 1959.
8.
Samuels, S.S. , AND Shaftel, H.E.: Use of a new vasodilator agent in management of peripheral anterial insufficiency. J. A. M. A., 171: 142, 1959.
9.
Weikel, J.H. , JR., Wheeler, A.C., AND Joiner, P.D.: Toxicology, absorption and physiological disposition of isoxsuprine (Vasodilan). Toxicol. and App. Pharmacol., 1: 579, 1959.
